45
DAFTAR PUSTAKA
1. Unemo M, William M. Antibiotic Resistance in Neisseria gonorrhoeae : Origin, Evolution, and Lessons Learned for the Future. [internet]. 2011.
[dikutip 22 Nov 2015]: Didapat dari:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510988/
2. Knilans K, Ventevogel M, Zhu W, Anderson J, Oldach L, Hobbs M, et al. Neisseria gonorrhoeae Supresses Dendritic Cell Induced, Antigen-Dependent CD4 T Cell Proliferation. [internet]. 2012. [dikutip 22 Nov
2015]: 7(7):2. Didapat dari:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402525/
3. Unemo M, William M. Antibiotic Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future. [internet]. 2014. [dikutip 23
Nov 2015]: 27(3):587. Didapat dari:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135894/
4. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveilance : Gonorrhea : Reported Cases and Rates of Reported Cases by State/Area and Region in Alphabetical Order, Unites States and Outlying Areas, 2010-2014. [internet]. 2014. [dikutip 17 Nov 2015]: Didapat dari: http://www.cdc.gov/std/stats14/tables/14.htm
5. Semarang Public Health. Health Profile in 2010 [internet]. Semarang: Semarang Public Health;2010. [dikutip 06 Des 2015]: Didapat dari: www.dinkes-kotasemarang.go.id.
6. Semarang Public Health. Health Profile in 2011 [internet]. Semarang: Semarang Public Health;2011. [dikutip 06 Des 2015]: Didapat dari: www.dinkes-kotasemarang.go.id
7. Allen G, Mitterni L, Seah C, Rabbapragada A, Martin E, Lee C, et al. Neisseria gonorrhoeae Treatment Failure and Suspectibility to Cefixime in Toronto, Canada. JAMA. [internet]. 2013. [dikutip 9 Jan 2016]:
309(2):163. Didapat dari:
http://jama.jamanetwork.com/article.aspx?articleid=1556149
8. CDC. Updated CDC’s Sexually Transmitted Disease treatment guidelines. Oral cephalosporin no longer a recommended treatment for gonococcal infection. [internet]. 2012. [dikutip 08 Des 2015]: 61(31):590. Didapat dari: http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf#page=55
9. Ohnisi M, Saika T, Hoshina S. Ceftriaxone Resistant Neisseria gonorrhoeae, Japan. [internet]. 2011. [dikutip 01 Jan 2016]: 17(1):148. Didapat dari: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204624/ 10. Ohnishi M, Golparian D. Is Neisseria gonorrhoeae Initiating a Future Era
of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone. [internet]. 2011. [dikutip 01
Jan 2016]: Didapat dari: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122416/
11. Rindi R, Rita E. Identification and Antibiotic Resistance Test Against
Neisseria gonorrhoeae In Vaginal Swab on Commercial Sex Workers at
Jondul, Rejosari, Tenayan Raya, Pekanbaru.[internet]. 2013. [dikutip 06 Jan 2016]: Didapat dari: repository.unri.ac.id.
12. Runtuboi R, Waworuntu L. Sensitivity Test Neisseria gonorrhoeae Against Multiple Antibiotics on Commercial Sex Workers at Lokalisasi Tanjung Elmo Jayapura. Papua Biologic Journal. [internet]. 2014. [dikutip 3 Nov 2015]: Didapat dari: ejournal.unicen.ac.id
13. Rahma D. The Difference in Sensitivity of Neisseria gonorrhoeae towards Kanamycin and Ceftriaxone in In vitro.[internet]. 2015. [dikutip 22 Jan 2016]: Didapat dari: eprints.undip.ac.id.
14. CDC. Antibiotic Resistant Threat in United States, 2013. [internet].2013.
[dikutip 03 Feb 2016]: Didapat dari:
http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf
15. Jawetz, Melnick, Adelberg. Medical Microbiology. Edisi ke-25. Jakarta: EGC; 2013. 256-60.
16. Pharmacology and Therapeutic Departement Medical Faculty of Indonesian University. Pharmacology and Therapi. Edisi ke-5. Jakarta: Balai Penerbit FK UI; 2007. 50-6.
17. Rx List the Internet Drug Index. Clinical Pharmacology : Mechanism of Action of Levofloxacin. [internet]. 2014 [dikutip 01 Jan 2016]: Didapat dari: http://www.rxlist.com/levaquin-drug/clinical-pharmacology.htm 18. Nightingale, Murakawa, Ambrose. Antimicrobial Pharmacodynamics In
Theory And Clinical Practice. Edisi ke-12. New York: Marcel Dekker, Inc; 2002. 20-4.
19. Brunton L, Lazo J, Parker K. Goodman & Gilman's The Pharmacological Basis of Therapeutics. Edisi ke-2. London: McGraw Hill Professional; 2015. 314-20.
20. Rashid N, Nadeem M. Formulation and in-vitro Evaluation of Levofloxacin Tablets by Using Different Superdisintegrants. American Journal of Research Communication. 2013. [dikutip 05 Feb 2016]: 1(4):193. Didapat dari: www.usa-journals.com
21. Croom K, Goa K. Levofloxacin. A Review Of Its Use In the Treatment of Bacterial Infection in United States. [internet]. 2013. [dikutip 14 Jan
2016]: 63(24):313. Didapat dari:
http://www.ncbi.nlm.nih.gov/pubmed/14664657
22. Anderson V, Perry C. Levofloxacin. A Review of Its Use as a High Dose, Short Course Treatment For Bacterial Infection. [internet]. 2008. [dikutip
05 Des 2015]: 68 (4):535. Didapat dari:
http://www.ncbi.nlm.nih.gov/pubmed/18318569
23. Martodihardjo S. Urethritis Gonorrhoea and non Gonorrhea Diagnostic and Therapy. Edisi ke-14. Jakarta: EGC; 2008. 1-17
24. Murtiastutik D. Sexual Transmitted Disease. Edisi Pertama. Surabaya: Airlangga University Press Surabaya, 2008. 109-14.
25. Bedeschi L, Pedroso C, Neto V, Souza V, Teixeira M. Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates from Patients Attending a Public Referral Centre for Sexually Transmitted Disease in Belo, Horizonte. States of Minas Gerais, Brazil. Revista da Sociedade Brasileira de Medicina Tropical. [internet]. 2013. [dikutip 23 Des 2015]: 46(3):304. Didapat dari: http://www.scielo.br/pdf/rsbmt/v46n3/0037-8682-rsbmt-46-03-304.pdf
26. Harvey R, Cornelison C, Fisher D. Microbiology. Edisi ke-3. London: Wolters Kluwer Health; 2012. 309-12.
27. Wong B. Gonorrhea [internet]. 2014. [dikutip 16 Des 2016]: Didapat dari: http://emedicine.medscape.com/article/218059-overview#aw2aab6b2b4aa 28. Medical Faculty of Indonesian University. Medical Microbiology. Edisi
ke-2. Jakarta: Binarupa Aksara Jakarta; 1994. 143-53.
29. Morse S, Ballard C, Holmes K, Moreland A. Atlas of Sexually Transmitted Disease and AIDS. Edisi ke-3. Spain: Mosby; 2003. 114-7. 30. Vipascita E. The Difference in Sensitivity of Neisseria gonorrhoeae
towards Azithromycin and Ceftriaxone in In vitro.[internet]. 2015. [dikutip 21 Des 2015]: Didapat dari: eprints.undip.ac.id.
31. Christy A. STD Awareness : Ceftriaxone-Resistant Gonorrhea. [internet].
http://advocatesaz.org/2015/12/07/std-awareness-ceftriaxone-resistant-gonorrhea/
32. Breithaupth H. Tackling resistence : Bacteria, humans, animals, and environtment: An Interview With Stuart Levy, Professor at Tufts University School of Medicine and President of the Alliance for the Prudent Use of Antibiotics. [internet]. 2014. [dikutip 15 Mei 2016]:
15(2):127. Didapat dari:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989856/
33. Wikler M. Performance Standards for Antimicrobial Suspectibility Testing, Clinical and Laboratory Standards Institute. Edisi ke-16. New York: Cornell Inc; 2011. 178.
34. Kementrian Kesehatan Republik Indonesia. Pedoman Nasional Penanganan Infeksi Menular Seksual. [internet]. 2011. [dikutip 24 Juni 2016]: Didapat dari: spiritia.or.id/dokumen/pedoman-ims2011.pdf
Lampiran 3. Data hasil penelitian SAMPE L KE- LEVOFLOKSASI N (mm) KESIMPULA N SEFTRIAKSO N (mm) KESIMPULA N 1 35 R 26 R 2 33 R 24 R 3 37 S 25 R 4 39 S 30 R 5 32 R 36 S 6 40 S 26 R 7 34 R 26 R 8 39 S 23 R 9 39 S 25 R 10 40 S 37 S 11 35 R 39 S 12 42 S 24 R 13 41 S 26 R 14 40 S 26 R 15 37 S 25 R 16 39 S 25 R 17 38 S 39 S 18 40 S 25 R 19 42 S 23 R 20 38 S 25 R 21 37 S 26 R 22 40 S 38 S 23 34 R 25 R 24 37 S 37 S 25 38 S 27 R 26 32 R 20 R
Lampiran 4. Analisis SPSS Crosstabs
Seftriakson * Levofloksasin Crosstabulation
4 2 6 4.4 1.6 6.0 21.1% 28.6% 23.1% 15 5 20 14.6 5.4 20.0 78.9% 71.4% 76.9% 19 7 26 19.0 7.0 26.0 100.0% 100.0% 100.0% Count Expected Count % wit hin Lev of loksasin Count
Expected Count % wit hin Lev of loksasin Count
Expected Count % wit hin Lev of loksasin Sensitif Resist en Sef triakson Total Sensitif Resist en Lev of loksasin Total Symmetric Measures -.047 .124 -.404 .686 26 Kappa Measure of Agreement N of Valid Cases Value Asy mp.
St d. Errora Approx. Tb Approx. Sig.
Not assuming the null hy pothesis. a.
Using the asy mptotic st andard error assuming the null hy pothesis. b.
Lampiran 5. Dokumentasi
1. Media transport kuman (Thayer Martin cair)
3. Koloni pada media thayer martin
5. Hasil tes oksidasi
Lampiran 6. Biodata Mahasiswa Identitas Peneliti
Nama : Dewi Ulfa Mei Saroh
NIM : 22010112110117
Tempat/tanggal lahir : Lamongan, 23 Mei 1994 Jenis Kelamin : Perempuan
Alamat : Jalan Raya Tanjung no 132 Lamongan, Jawa Timur Nomor Telepon : 082225921715
e-mail : dewiulfams@yahoo.com
Riwayat Pendidikan Formal
1. SD : SD Negeri Tanjung Lamongan Lulus tahun : 2006 2. SMP : SMP Negeri 1 Lamongan Lulus tahun : 2009 3. SMA : SMA Negeri 2 Lamongan Lulus tahun : 2012 4. FK UNDIP : Masuk tahun : 2012
